Get Brochure

SERVICES

Regulatory Services in USA

Regulatory Compliance Experts in USA

A robust regulatory system is important to ensure the safety, efficacy, and quality from pre-marketing to post-marketing phases of a medicinal product. The U.S. FDA is the governing regulatory authority in the USA for medicines, medical devices, biosimilars, vaccines, food supplements, Pharmacovigilance solutions, cosmetics, and more. The Center for Drug Evaluation and Research (CDER) issues different requirements for new drugs, generic drugs, and OTC drugs including New Drug applications (NDAs) and Abbreviated New Drug Applications (ANDAs). For new biologics a Biologics Licenses Application (BLA) is necessary for premarket approval. Thus, the U.S. FDA sets strict guidelines that manufacturers must follow to obtain compliant market authorization for their products depending on their category, which are also adopted by many other countries worldwide. However, due to the stringency of the guidelines and the ever-changing regulations many foreign manufacturers are unable to obtain compliant market authorization for their products.

As a leading global contender, DDReg’s Regulatory Services in USA provides on-going support and development of the customized strategies during all regulatory phases while keeping track of the most recent regulatory requirements to ensure high quality and timely submissions. We deliver reliable safety measures, ensure risk mitigation, and collaborate with experts to facilitate effortless delivery of product launches, regulatory filings, and market authorizations. For the U.S. market, we provide comprehensive services for NDA and ANDA applications as per sections 505 (b)(2) and 505(j) respectively. In-house or monograph specifications, protocols, reports, and completed ANDA or NDA dossiers (modules 1, 2, 3, and 5) are thoroughly reviewed as per the U.S. FDA requirements. All queries are responded to and include adequacy review for submission. All post-approval or minor changes are conducted including annual reports filing and prior approval supplement. We provide assistance for all ANDA requests made by the U.S. FDA.

Our Regulatory Consulting Services In USA Portfolio Covers

  • Regulatory Strategies and Expert Views
  • Regultory Due Diligence
  • Gap Analysis and Remediation
  • New Product Authorizations
  • Post Approval Life Cycle Management
  • CMC Advisory
  • API/DMF

Our Regulatory Affairs Consulting Services portfolio covers:

Strategies

Regulatory Strategies / Expert Views

Regulations pertaining to pharmaceutical products are continuously changing...

Read More➔
Authorizations

New Product Authorizations

Pharmaceuticals and other medicinal products need to be prior authorized by...

Read More➔
Analysis

Gap Analysis and Remediation

A gap analysis is a regulatory review process that identifies data gaps in the technical...

Read More➔
delig

Regulatory Due Diligence

Regulatory issues arise unexpectedly and can create significant strain on a company’s...

Read More➔
Authorizations

API/DMF

DDReg provides expert consulting and efficient services for quality Drug Substance...

Read More➔
CMC

CMC Advisory

When it comes to regulatory strategies, CMC documentation play a crucial role in developing...

Read More➔

Post Approval Life Cycle Management

Managing the post-approval life cycle of a product is an essential component to sustaining...

Read More➔
Regulatory Certification

Regulatory Certification

Administrative documents are an integral component of regulatory submissions and constitute key certifications...

Read More➔
Regulatory Certification

ANDA and MA Holder Services

The regulatory approval pathway for Abbreviated New Drug Applications (ANDAs) is relatively complex....

Read More➔
Contact our experts today !
Country Specific Services

How can we help you?
Call us on:+1 (302) 601-2755